Garry Fenton

Selective Type IV Phosphodiesterase Inhibitors as Antiasthmatic Agents. The Syntheses and Biological Activities of 3-(Cyclopentyloxy)-4-methoxybenzamides and Analogs

Michael J. Ashton, David Cook, Garry Fenton et al. · Journal of Medicinal Chemistry · 1994 · 112 citations · Full text

Antiparasitic Agent, Pde Iv, Biological Activities +17

Chemoselective debenzylation of N-benzyl tertiary amines with ceric ammonium nitrate

Steven D. Bull, Stephen G. Davies, Garry Fenton et al. · Journal of the Chemical Society Perkin Transactions 1 · 2000 · 88 citations

Chemical Engineering, Novel Organocatalysts, Engineering +9

Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes

Jon M. Sutton, David E. Clark, Stephen J. Dunsdon et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 68 citations · Full text

Diabetes Management, Biochemistry, Medicine +8

Hypolipidemic 2-[4-(1,1-dimethylethyl)phenyl]-4H-3,1-benzoxazin-4-ones. Structure-activity relationships of a novel series of high-density lipoprotein elevators

Garry Fenton, Christopher G. Newton, Barry M. Wyman et al. · Journal of Medicinal Chemistry · 1989 · 64 citations

Mapping the kinase domain of janus kinase 3

Christopher Adams, David Aldous, Shelley Amendola et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 50 citations · Full text

Signal Transduction, Molecular Physiology, Signaling Pathway +9